Skip to main content

Table 6 Odds Ratios for All-Cause Discontinuation and Discontinuation Due to Adverse Events

From: Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

PLO

1.68 [1.09, 2.48]

1.05 [0.77, 1.41]

0.70 [0.48, 1.00]

0.99 [0.78, 1.24]

1.38 [0.92, 1.98]

1.10 [0.61, 1.83]

2.47 [1.10, 4.90]

ARI

0.66 [0.38, 1.06]

0.44 [0.24, 0.73]

0.62 [0.37, 0.96]

0.86 [0.47, 1.45]

0.68 [0.32, 1.28]

1.50 [0.82, 2.64]

0.70 [0.25, 1.64]

CAR

0.68 [0.42, 1.06]

0.96 [0.64, 1.37]

1.34 [0.79, 2.11]

1.07 [0.54, 1.90]

1.43 [0.68, 2.58]

0.67 [0.21, 1.57]

1.04 [0.37, 2.23]

OLA

1.46 [0.93, 2.18]

2.03 [1.15, 3.30]

1.62 [0.79, 2.95]

2.46 [1.57, 3.75]

1.15 [0.44, 2.49]

1.79 [0.80, 3.42]

1.93 [0.82, 4.09]

QUE

1.41 [0.88, 2.15]

1.12 [0.59, 1.95]

1.54 [0.76, 2.80]

0.72 [0.23, 1.70]

1.12 [0.41, 2.37]

1.21 [0.43, 2.82]

0.66 [0.27, 1.32]

ZIP

0.83 [0.40, 1.54]

1.12 [0.36, 2.76]

0.52 [0.12, 1.50]

0.81 [0.21, 2.23]

0.88 [0.22, 2.50]

0.48 [0.14, 1.24]

0.81 [0.20, 2.27]

LUR

  1. Note: All-Cause Discontinuation results are on the top-right and Discontinuation Due to Adverse Events are in the bottom left. Results give the odds ratio [95% credible interval]. In the top-right comparisons, the row treatment is the reference category. In the bottom-left, the column treatment is the reference category
  2. Abbreviations: PLO Placebo, ARI Aripiprazole, CAR Cariprazine, LUR Lurasidone, OLA Olanzapine, QUE Quetiapine, ZIP Ziprasidone